Abstract
Objectives: A new national clinical guideline for the management of tuberculosis and HIV in Iranian prisons was released in 2011. The aim of this study was to compare HIV indicators in the case and control prisons after implementation of the new guideline.
Methods: This report examines outcomes observed during the pilot phase of its implementation at a case prison from October 2013 to June 2014 compared to a control prison that had not yet implemented the guideline. The case prison included incarcerated individuals in the Great Tehran Prison. A prison in Alborz province was considered as a control group. Pearson’s Chi-squared, two-sample t-test, paired t-test and Kruskal-Wallis were used for the analysis.
Results: The intervention significantly increased the total number of inmates tested for HIV and of diagnoses of HIV-positive inmates in the case prison compared to the control prison (P<0.001). Moreover, coverage of antiretroviral therapy was higher in the case prison compared to the control prison (P=0.015).
Conclusion: We recommend the implementation of this guideline in all Iranian prisons.
Keywords: HIV/AIDS, prison, guideline, indicators, HIV testing, antiretroviral therapy.
Infectious Disorders - Drug Targets
Title:Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison
Volume: 20 Issue: 6
Author(s): Behnam Farhoudi, SeyedAhmad SeyedAlinaghi*, Bahar Ataeinia, Mostafa Hosseini, Sirous Jafari, Ramin Alasvand, Mehrzad Tashakoriyan and Minoo Mohraz
Affiliation:
- Iranian Research Center for HIV/AIDS, Tehran University of Medical Sciences, Tehran,Iran
Keywords: HIV/AIDS, prison, guideline, indicators, HIV testing, antiretroviral therapy.
Abstract:
Objectives: A new national clinical guideline for the management of tuberculosis and HIV in Iranian prisons was released in 2011. The aim of this study was to compare HIV indicators in the case and control prisons after implementation of the new guideline.
Methods: This report examines outcomes observed during the pilot phase of its implementation at a case prison from October 2013 to June 2014 compared to a control prison that had not yet implemented the guideline. The case prison included incarcerated individuals in the Great Tehran Prison. A prison in Alborz province was considered as a control group. Pearson’s Chi-squared, two-sample t-test, paired t-test and Kruskal-Wallis were used for the analysis.
Results: The intervention significantly increased the total number of inmates tested for HIV and of diagnoses of HIV-positive inmates in the case prison compared to the control prison (P<0.001). Moreover, coverage of antiretroviral therapy was higher in the case prison compared to the control prison (P=0.015).
Conclusion: We recommend the implementation of this guideline in all Iranian prisons.
Export Options
About this article
Cite this article as:
Farhoudi Behnam, SeyedAlinaghi SeyedAhmad*, Ataeinia Bahar, Hosseini Mostafa, Jafari Sirous, Alasvand Ramin, Tashakoriyan Mehrzad and Mohraz Minoo, Comparison of HIV Indicators after the Implementation of a New Model for TB and HIV Management in an Iranian Prison, Infectious Disorders - Drug Targets 2020; 20 (6) . https://dx.doi.org/10.2174/1871526519666191015151639
DOI https://dx.doi.org/10.2174/1871526519666191015151639 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Organic Antifungal Drugs and Targets of Their Action
Current Topics in Medicinal Chemistry Corticosteroid as an Adjunct in the Treatment of Endobronchial Tuberculosis: A Systematic Review & Meta-analysis
Current Pediatric Reviews Trick-or-Treat: Dietary Lipids and Host Resistance to Infectious Disease
Mini-Reviews in Medicinal Chemistry LYS70 of E. coli Quinolinate Phosphoribosyltransferase Is Protected from Chemical Modification by Formation of an Inhibitor Complex.
Protein & Peptide Letters Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology
Current Pharmaceutical Design The Potent Antiplasmodial Calmodulin-Antagonist Trifluoperazine Inhibits Plasmodium falciparum Calcium-Dependent Protein Kinase 4
Protein & Peptide Letters Subject Index To Volume 13
Current Medicinal Chemistry Emergence of Heteroresistance Mycobacterium Tuberculosis in Saudi Arabia
Infectious Disorders - Drug Targets DC-SIGN Antagonists, a Potential New Class of Anti-Infectives
Current Medicinal Chemistry 1, 4-Dihydropyridines: A Class of Pharmacologically Important Molecules
Mini-Reviews in Medicinal Chemistry A Comprehensive Review on the Biological and Pharmacological Activities of Rhodanine Based Compounds for Research and Development of Drugs
Mini-Reviews in Medicinal Chemistry Identification of Cancerlectins By Using Cascade Linear Discriminant Analysis and Optimal g-gap Tripeptide Composition
Current Bioinformatics Quinoline – a Promising Fragment in the Search for New Antimalarials
Mini-Reviews in Medicinal Chemistry Drug Design for Neglected Disease in Brazil
Mini-Reviews in Medicinal Chemistry Novel Urea/Thiourea Derivatives of Quinazolin-4(3H)-one: Design, Synthesis, Antimicrobial and Anti-TB Study
Letters in Drug Design & Discovery Design of Novel Phosphopantetheine Adenylyltransferase Inhibitors: A Potential New Approach to Tackle <i>Mycobacterium tuberculosis</i>
Current Topics in Medicinal Chemistry Hybrid Drugs as Potential Combatants Against Drug-Resistant Microbes: A Review
Current Topics in Medicinal Chemistry Mechanisms of Plant Defense Under Pathogen Stress: A Review
Current Protein & Peptide Science Double Infection in a Patient with Psoriatic Arthritis Under TNF-alpha Blockers Therapy: A Case Report
Current Drug Safety Biospecies Capture and Detection at Low Concentration
Micro and Nanosystems